Canaccord Genuity Reiterates a 'Buy' on Descartes (DSGX); No Holes in This Quarter; Upside Revenue and EBITDA
Get Alerts DSGX Hot Sheet
Price: $78.21 +0.49%
Rating Summary:
11 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
11 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Canaccord Genuity reiterates a 'Buy' on Descartes (NASDAQ: DSGX) price target of $10.
Canaccord analyst, Richard Davis, said, "DSGX shares, even adjusting for thin volume on NASDAQ, seem quite inexpensive compared to what we believe is a marked and continuing improvement in the firm’s fundamental execution and outlook. We have no hesitation recommending purchase of the stock at current, and higher, levels. We believe there is every reason for this stock to reach at least $10 within a year."
For more ratings news on Descartes click here and for the rating history of Descartes click here.
Shares of Descartes closed at $6.59 yesterday.
Canaccord analyst, Richard Davis, said, "DSGX shares, even adjusting for thin volume on NASDAQ, seem quite inexpensive compared to what we believe is a marked and continuing improvement in the firm’s fundamental execution and outlook. We have no hesitation recommending purchase of the stock at current, and higher, levels. We believe there is every reason for this stock to reach at least $10 within a year."
For more ratings news on Descartes click here and for the rating history of Descartes click here.
Shares of Descartes closed at $6.59 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Descartes launches AI document management tool for customs processing
- Ferrovial SA (FER:SM) (FRRVF) Reiterated at Buy by UBS on Winning Bid For Tennessee Project
- Advance Auto Parts (AAP) PT Lowered to $48 at DA Davidson Following 25% Selloff Post Q2 Results
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share